Infliximab therapy in established rheumatoid arthritis: An observational study
- 1 May 2005
- journal article
- research article
- Published by Elsevier in The American Journal of Medicine
- Vol. 118 (5), 515-520
- https://doi.org/10.1016/j.amjmed.2005.01.029
Abstract
No abstract availableThis publication has 21 references indexed in Scilit:
- Definition of discontinuation of anti-tumour necrosis factor therapy in rheumatoid arthritis: a preliminary proposalAnnals Of The Rheumatic Diseases, 2003
- Methotrexate Intolerance in Elderly Patients with Rheumatoid ArthritisDrugs & Aging, 2003
- Newer Immunosuppressive DrugsDrugs, 2002
- Infliximab and Methotrexate in the Treatment of Rheumatoid ArthritisNew England Journal of Medicine, 2000
- Infliximab (chimeric anti-tumour necrosis factor α monoclonal antibody) versus placebo in rheumatoid arthritis patients receiving concomitant methotrexate: a randomised phase III trialThe Lancet, 1999
- Therapeutic efficacy of multiple intravenous infusions of anti-tumor necrosis factor ? monoclonal antibody combined with low-dose weekly methotrexate in rheumatoid arthritisArthritis & Rheumatism, 1998
- American college of rheumatology preliminary definition of improvement in rheumatoid arthritisArthritis & Rheumatism, 1995
- Modified disease activity scores that include twenty-eight-joint counts development and validation in a prospective longitudinal study of patients with rheumatoid arthritisArthritis & Rheumatism, 1995
- Rheumatoid ArthritisNew England Journal of Medicine, 1990
- The american rheumatism association 1987 revised criteria for the classification of rheumatoid arthritisArthritis & Rheumatism, 1988